Pharmacy Support for Rehabilitation Adherence: Mechanisms, Clinical Relevance, and Evidence-Based Interventions

Abstract

Effective rehabilitation is central to optimal recovery in patients with acute and chronic illnesses, yet adherence to rehabilitation regimens remains a significant barrier to therapeutic success. Pharmacists, positioned at the intersection of patient care and medication management, can play a pivotal role in supporting rehabilitation adherence. This review synthesizes current evidence on the epidemiology, underlying mechanisms, risk factors, clinical features, diagnostic considerations, and management strategies related to rehabilitation adherence, with a focus on pharmacy-driven interventions. It explores recent advances, emerging therapies, and guideline recommendations, providing a comprehensive framework for integrating pharmacy support into multidisciplinary rehabilitation programs.

Introduction

Rehabilitation adherence refers to the extent to which patients follow prescribed physical, occupational, speech, or cognitive therapy regimens. Poor adherence is a pervasive issue, often resulting in suboptimal outcomes, increased healthcare utilization, and diminished quality of life. Pharmacists, as accessible healthcare professionals, are uniquely positioned to address barriers to adherence through patient education, medication reconciliation, motivational interviewing, and collaboration with the rehabilitation team. Understanding the mechanisms and clinical implications of pharmacy support in this domain is essential for optimizing patient-centered care.

Epidemiology / Disease Burden

Non-adherence to rehabilitation protocols affects 30-50% of patients across various clinical populations, including those recovering from stroke, orthopedic procedures, cardiac events, and chronic pulmonary diseases. Epidemiological studies indicate that low adherence is associated with higher rates of rehospitalization, delayed functional recovery, and increased long-term morbidity. The economic burden is substantial, with non-adherence contributing to billions in avoidable healthcare costs globally. Identifying vulnerable populations and quantifying the extent of non-adherence are critical steps toward targeted interventions.

Pathophysiology

The pathophysiology of rehabilitation non-adherence is multifactorial. Cognitive impairment, medication side effects, pain, fatigue, and psychological comorbidities such as depression and anxiety can impede participation in rehabilitation activities. Furthermore, complex medication regimens may interact with rehabilitation by inducing sedation, orthostatic hypotension, or motor impairments. Pharmacists can identify and mitigate medication-related barriers, tailoring pharmacotherapy to facilitate active participation in rehabilitation.

Risk Factors

Several risk factors predispose patients to poor rehabilitation adherence. These include advanced age, polypharmacy, impaired health literacy, socioeconomic constraints, lack of social support, and insufficient understanding of rehabilitation goals. Medical complexity, such as coexisting cardiovascular or musculoskeletal disorders, further complicates adherence. Pharmacists can proactively screen for these risk factors using validated assessment tools and initiate early interventions.

Clinical Features

Clinically, non-adherence may manifest as missed therapy sessions, incomplete home exercise programs, or suboptimal engagement during supervised rehabilitation. Patients may report medication-related adverse effects, confusion regarding medication timing relative to therapy, or perceiving little benefit from rehabilitation. Pharmacists, through direct patient interaction, can detect these features early and implement corrective strategies, such as regimen simplification, adverse effect management, and reinforcement of the rehabilitation rationale.

Diagnosis

Diagnosis of rehabilitation non-adherence involves a combination of patient self-report, therapist documentation, and objective monitoring tools, such as electronic adherence trackers or wearable devices. Pharmacists contribute by reviewing medication refill histories, conducting adherence interviews, and collaborating with the rehabilitation team to identify patterns of disengagement. Comprehensive assessment enables the formulation of individualized adherence support plans.

Treatment & Management

Management strategies for rehabilitation adherence are multidisciplinary. Pharmacists provide medication counseling, clarify the role of pharmacotherapy in facilitating rehabilitation, and educate patients about potential drug-therapy interactions. Interventions include medication synchronization, adherence packaging, motivational interviewing, and the use of reminder systems. Collaborative care models, where pharmacists participate in rehabilitation team meetings, enhance communication and enable rapid adjustment of pharmacologic and non-pharmacologic regimens to optimize adherence.

Recent Advances / Emerging Therapies

Recent advances in pharmacy support for rehabilitation adherence include the integration of digital health technologies, such as mobile applications and telepharmacy, to deliver remote counseling and adherence monitoring. Pharmacogenomic testing is emerging as a tool to personalize medication regimens, minimizing adverse effects that deter participation in rehabilitation. Additionally, pharmacist-led transitional care programs have demonstrated reductions in rehospitalization and improved function in post-acute care populations. These advances underscore the evolving role of pharmacists in rehabilitation medicine.

Guideline Recommendations

International and national guidelines increasingly recognize the importance of multidisciplinary approaches to rehabilitation adherence. The American Society of Health-System Pharmacists and the World Health Organization advocate for pharmacist involvement in medication management and patient education during rehabilitation. Key recommendations include routine medication reviews, interprofessional communication, proactive identification of adherence barriers, and ongoing patient engagement. Adherence support should be customized to patient needs and integrated into the continuum of care.

Conclusion

Rehabilitation adherence is a critical determinant of recovery across a spectrum of acute and chronic conditions. Pharmacists, through their expertise in medication management and patient education, can substantially enhance adherence to rehabilitation regimens. Evidence-based pharmacy interventions, coupled with multidisciplinary collaboration, offer a pragmatic and effective approach to overcoming barriers to rehabilitation engagement. Embracing recent advances and guideline recommendations will be essential for realizing the full potential of pharmacy support in rehabilitation medicine and improving patient outcomes.